<DOC>
	<DOC>NCT03071510</DOC>
	<brief_summary>The objective of the study is to compare Atlas Genetics io® system results with those obtained from comparator devices.</brief_summary>
	<brief_title>Evaluation of the Atlas Genetics io® CTNG System</brief_title>
	<detailed_description />
	<mesh_term>Gonorrhea</mesh_term>
	<criteria>1. Symptomatic and asymptomatic individuals ≥14 years of age 1. Treatment with antibiotics known to be effective against Chlamydia trachomatis and/or Neisseria gonorrhoeae within the previous 4 weeks before inclusion in the study. 2. Unable to selfobtain a vaginal swab or urine sample of at least 30 mL</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>